N/A
N=1,957
The COPENHAGEN Puberty Study
Puberty
Bottom Line
View on ClinicalTrials.gov: NCT01411527 ↗Enrolled (actual)
1,957
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Pubertal Onset — 9.86; 9.86; 11.66; 11.66 years
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult · 5+ yrs
- Sex
- All
- Sponsor
- Rigshospitalet, Denmark
- Primary completion
- Dec 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pubertal Onset |
9.86; 9.86; 11.66; 11.66 | — |
Summary
By clinical examinations and withdrawing of blood samples from a large number of healthy Danish children, this study will reveal if age of pubertal onset is declining. Furthermore, the extensive normative data will provide detailed insight into normal ranges and individual changes of anthropometrics and hormone levels in healthy children during childhood and adolescence.
Eligibility Criteria
Inclusion Criteria
- all children accepting to participate were included
Exclusion Criteria
- no children were excluded from examination or blood sampling. In case of chronic diseases, medical treatment, or ethnicity the children may be excluded from specific final data analysis.
Data sourced from ClinicalTrials.gov (NCT01411527). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.